There’s a new Muse in town. Sanofi, Formation Bio and OpenAI have joined forces ... “Muse is just the start—one of the many ...

Today, Formation Bio, together with OpenAI and Sanofi, introduced Muse, an advanced AI-powered tool developed to accelerate and improve drug development by optimizing patient recruitment for clinical ...

New Delhi: Reviewing the Phase III clinical trial protocol of the GZ402671 (Venglustat) presented by the pharma major Sanofi, ...

The expert panel further added, "The safety and efficacy data are to be deliberated in the presence of an independent expert ...

Life sciences expert Jennie Taveras has joined STO Building Group to lead the company’s growth in the life sciences sector ...

Dr. Meijing Wu is described by friends and colleagues as a distinguished biostatistician and “a kind and generous friend who ...

By using automated content recognition, Beatgrid can measure cross-platfrom ad exposure by individual as well as the ...

Sanofi said this morning that its pipeline includes ... build-up to an R&D presentation to investors that will be held in New York later today, and also after the France-headquartered group ...

CN Bio, a leading provider of Organ-on-a-chip Systems and solutions that accelerate drug discovery and development workflows, today announced the launch of its PhysioMimix® Bioavailability assay kit: ...

"Sanofi's collaboration with Exscientia aims to transform how we discover and develop new small molecule medicines for cancer and immune-mediated diseases," said the pharma group's chief ...

The new partnership builds on earlier collaborations like the Spokes Project that saw SSPC and NIBRT work with Allergan, ...